CMS Open Payments · Program Year 2024
Maine
Maine received $3,474,181.60 in pharmaceutical-industry payments to 1,882 physicians and 4 teaching hospitals across 19,652 transactions.
- $3.5M
- Total payments
- $3.0M
- To physicians
- $117.7K
- To teaching hospitals
- #47
- of 59 states
In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $3.5M in payments to 1,882 physicians and 4 teaching hospitals in Maine. That ranks Maine #47 of 59 states and territories (0.0% of the US total), averaging $1.6K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.
The verdict
Maine pairs modest payment volume with an overwhelmingly physician-directed payment mix.
- #47
- of 59 states
- 0.0%
- of the national total
- 87.2%
- to physicians vs. hospitals
- 1,882
- physicians paid
What the Data Shows for Maine
Maine sits in the lower-volume tercile at #47 of 59 (0.0% of US dollars). The PY2024 file still records $3,474,181.60 across 19,652 transactions.
The distinctive cut versus volume is the physician share: 87.2% of dollars to 1,882 physicians ($1.6K each). Average transaction $176.79. Leading nature of payment: "Consulting Fee" at $902.0K (26.0% of the state file; top-three natures 61.1%).
Maine sits in the 22nd percentile (lower-volume tier). Just above: Delaware ($4.3M). Just below: Montana ($2.8M). For context: top-ranked California ($342.4M) is 98.6× larger than Maine. CMS Sunshine Act framework and methodology.
Physician vs Hospital Payments
How pharmaceutical payments in Maine are distributed between physicians and teaching hospitals.
Physician Payments
$3.0M
87.2% of total · 1,882 recipients · $1.6K avg
Teaching Hospital Payments
$117.7K
3.4% of total · 4 hospitals · $29.4K avg
Payment Breakdown by Type
Maine has 15 types of pharmaceutical payments. "Consulting Fee" accounts for 26.0%.
Nature concentration in Maine
Top three Open Payments natures are 61.1% of state dollars; residual is every other reported nature
Payment categories in Maine
Top categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of State |
|---|---|---|---|
| Consulting Fee | $902.0K | 433 | 26.0% |
| Compensation for Services Other Than Consulting | $639.5K | 294 | 18.4% |
| Food and Beverage | $580.3K | 16,985 | 16.7% |
| Travel and Lodging | $406.6K | 1,273 | 11.7% |
| Royalty or License | $285.2K | 30 | 8.2% |
| Debt Forgiveness | $170.2K | 11 | 4.9% |
| Grant | $134.3K | 13 | 3.9% |
| Education | $116.9K | 360 | 3.4% |
| Honoraria | $113.1K | 65 | 3.3% |
| Compensation for Faculty or Speaker (Medical Education) | $75.1K | 50 | 2.2% |
| Long-Term Medical Supply or Device Loan | $27.7K | 19 | 0.8% |
| Space Rental or Facility Fees | $10.3K | 5 | 0.3% |
| Gift | $6.9K | 90 | 0.2% |
| Charitable Contribution | $4.0K | 1 | 0.1% |
| Entertainment | $1.8K | 23 | 0.1% |
Read with this Maine Open Payments read
Volume neighbors, physician-share peers, and the national nature catalog, not the same three guides on every state page.
- Next higher total: Delaware ($4.3M)
- Next lower total: Montana ($2.8M)
- Nearest physician-share mix: Maryland (87.3% to physicians)
- Nearest physician-share mix: Wyoming (86.7% to physicians)
- Nearest physician-share mix: Idaho (87.8% to physicians)
- National catalog for leading nature here: Consulting Fee (26.0% of Maine)
- State payment rankings (includes Maine at #47)
- How Open Payments natures are defined
Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.
Read our methodology - how this data is sourced, computed, and verified.
Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024
What Maine totals can and cannot tell you
The aggregate payment figure for Maine measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.
Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.